Donald J Kellerman - Net Worth and Insider Trading

Donald J Kellerman Net Worth

The estimated net worth of Donald J Kellerman is at least $0 dollars as of 2024-04-29. Donald J Kellerman is the VP, Clinical Dev & Med Affairs of Zosano Pharma Corp and owns about 1,609 shares of Zosano Pharma Corp (ZSANQ) stock worth over $0. Details can be seen in Donald J Kellerman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Donald J Kellerman has not made any transactions after 2022-03-31 and currently still holds the listed stock(s).

Transaction Summary of Donald J Kellerman

To

Donald J Kellerman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Donald J Kellerman owns 2 companies in total, including Zosano Pharma Corp (ZSANQ) , and Tonix Pharmaceuticals Holding Corp (TNXP) .

Click here to see the complete history of Donald J Kellerman’s form 4 insider trades.

Insider Ownership Summary of Donald J Kellerman

Ticker Comapny Transaction Date Type of Owner
ZSANQ Zosano Pharma Corp 2022-03-31 VP & Clinical Dev & Med Affairs
TNXP Tonix Pharmaceuticals Holding Corp 2014-04-01 See Remarks

Donald J Kellerman Latest Holdings Summary

Donald J Kellerman currently owns a total of 1 stock. Donald J Kellerman owns 1,609 shares of Zosano Pharma Corp (ZSANQ) as of March 31, 2022, with a value of $0.

Latest Holdings of Donald J Kellerman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZSANQ Zosano Pharma Corp 2022-03-31 1,609 0.00 0

Holding Weightings of Donald J Kellerman


Donald J Kellerman Form 4 Trading Tracker

According to the SEC Form 4 filings, Donald J Kellerman has made a total of 2 transactions in Zosano Pharma Corp (ZSANQ) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zosano Pharma Corp is the sale of 114 shares on March 31, 2022, which brought Donald J Kellerman around $841.

Insider Trading History of Donald J Kellerman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Donald J Kellerman Trading Performance

GuruFocus tracks the stock performance after each of Donald J Kellerman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Donald J Kellerman is -52.77%. GuruFocus also compares Donald J Kellerman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Donald J Kellerman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Donald J Kellerman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Donald J Kellerman

Average Return

-34.52%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -40 -52.77 149.6 -34.52 -60.5 -52.03
Relative Return to S&P 500(%) -37.95 -52.68 141.94 -45.59 -74.78 -62.24

Donald J Kellerman Ownership Network

Ownership Network List of Donald J Kellerman

No Data

Ownership Network Relation of Donald J Kellerman


Donald J Kellerman Owned Company Details

What does Zosano Pharma Corp do?

Who are the key executives at Zosano Pharma Corp?

Donald J Kellerman is the VP & Clinical Dev & Med Affairs of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include Chief Financial Officer Christine Matthews , director & Chief Executive Officer Steven Lo , and See Remarks Hayley Lewis .

Zosano Pharma Corp (ZSANQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zosano Pharma Corp Insider Transactions

No Available Data

Donald J Kellerman Mailing Address

Above is the net worth, insider trading, and ownership report for Donald J Kellerman. You might contact Donald J Kellerman via mailing address: Inspire Pharmaceuticals, Inc.,, 4222 Emperor Blvd., Ste. 470, Durham Nc 27703-8466.

Discussions on Donald J Kellerman

No discussions yet.